Childhood immune thrombocytopenia: A nationwide cohort study on condition management and outcomes

Objectives Nationwide prospective cohort study exploring (i) the factors associated with treatment initiation (vs. watchful waiting) in children with primary immune thrombocytopenia (ITP) followed in routine clinical practice and (ii) the predictors of chronicity at 12 months. Procedure Between 2008...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric blood & cancer 2017-07, Vol.64 (7), p.n/a
Hauptverfasser: Grimaldi‐Bensouda, Lamiae, Nordon, Clémentine, Leblanc, Thierry, Abenhaim, Lucien, Allali, Slimane, Armari‐Alla, Corinne, Berger, Claire, Courcoux, Mary‐France, Fouyssac, Fanny, Guillaumat, Cécile, Guitton, Corinne, Le Moine, Philippe, Mazingue, Françoise, Pondarré, Corinne, Thomas, Caroline, Pasquet, Marlène, Perel, Yves, Leverger, Guy, Aladjidi, Nathalie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives Nationwide prospective cohort study exploring (i) the factors associated with treatment initiation (vs. watchful waiting) in children with primary immune thrombocytopenia (ITP) followed in routine clinical practice and (ii) the predictors of chronicity at 12 months. Procedure Between 2008 and 2013, 23 centers throughout France consecutively included 257 children aged 6 months–18 years and diagnosed with primary ITP over a 5‐year period. Data on ITP clinical features along with medical management were collected at baseline and 12 months. Multivariate logistic regressions were used to determine (i) and (ii) as defined above, providing odds ratio (OR) with 95% confidence interval (95% CI). Results One hundred thirty‐seven (53%) children were males, median age was 4.6 years, median platelet count was 7 × 109/l, and 214 (81%) patients initiated medication. Factors independently associated with treatment initiation included platelet counts
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.26389